Literature DB >> 9010051

Synovial fluid interleukin-8 and neutrophil function in rheumatoid arthritis and seronegative polyarthritis.

P R Troughton1, R Platt, H Bird, E el-Manzalawi, M Bassiouni, V Wright.   

Abstract

The relationships between synovial fluid (SF) interleukin-8 (IL-8) and neutrophil turnover as measured by cytidine deaminase (CD), and SF metabolites were studied in 28 patients, 16 with rheumatoid arthritis (RA; median age and disease duration 62 and 14 yr, respectively) and 12 with seronegative polyarthritis (SNP; median age and disease duration 32 and 5 yr, respectively). Knee SF samples were aspirated using indwelling cannulae following a period of rest for 1 h. SF IL-8 levels (measured by an ELISA) were significantly elevated in RA compared to SNP (median 2.35 vs 0.22 ng/ml, P < 0.001), as were median levels of CD (55.8 vs 8.11 U/ml, P < 0.01), lactic acid (29.6 vs 16.6 mg/dl, P < 0.001), glucose (57.9 vs 84.5 mg/dl, P < 0.05) and the lactate to glucose ratio (0.85 vs 0.19, P < 0.001). Measures of disease activity, C-reactive protein, plasma viscosity and articular index were also elevated in RA compared to SNP (P < 0.05). SF IL-8 levels correlated strongly with CD, lactate, glucose and the lactate to glucose ratio when both disease groups were considered together (P < 0.001). These parameters also showed some association with the measures of disease activity (P < 0.05). All these associations were less marked when the individual disease groups were analysed separately. These results suggest that factors responsible for neutrophil accumulation and priming (probably IL-8) are present in SF, and these coincide with products of their activation (CD). The degree of neutrophil turnover is linked to the anaerobic metabolism of the synovial cavity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9010051     DOI: 10.1093/rheumatology/35.12.1244

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  9 in total

1.  Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases.

Authors:  A S Taha; V Grant; R W Kelly
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

2.  The DEK nuclear autoantigen is a secreted chemotactic factor.

Authors:  Nirit Mor-Vaknin; Antonello Punturieri; Kajal Sitwala; Neil Faulkner; Maureen Legendre; Michael S Khodadoust; Ferdinand Kappes; Jeffrey H Ruth; Alisa Koch; David Glass; Lilli Petruzzelli; Barbara S Adams; David M Markovitz
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

3.  Cytidine deaminase in polymyalgia rheumatica and elderly onset rheumatoid arthritis.

Authors:  Sergio Paira; Susana Roverano; Oscar Rillo; Alejandra Barrionuevo; Stella Mahieu; Néstor Millen
Journal:  Clin Rheumatol       Date:  2005-01-22       Impact factor: 2.980

4.  Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients.

Authors:  N Olsson; A K Ulfgren; G Nilsson
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 5.  Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications.

Authors:  Ursula Fearon; Megan M Hanlon; Achilleas Floudas; Douglas J Veale
Journal:  Nat Rev Rheumatol       Date:  2022-04-19       Impact factor: 32.286

6.  Hyaluronidase decreases neutrophils infiltration to the inflammatory site.

Authors:  Marcio Fronza; Cornélia Muhr; Denise Sayuri Calheiros da Silveira; Carlos Artério Sorgi; Stephen Fernandes de Paula Rodrigues; Sandra Helena Poliselli Farsky; Francisco Wanderley Garcia Paula-Silva; Irmgard Merfort; Lúcia Helena Faccioli
Journal:  Inflamm Res       Date:  2016-03-04       Impact factor: 4.575

Review 7.  Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.

Authors:  Etheresia Pretorius; Oore-Ofe Akeredolu; Prashilla Soma; Douglas B Kell
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-26

8.  TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.

Authors:  Lilian Quero; Edveena Hanser; Tobias Manigold; André N Tiaden; Diego Kyburz
Journal:  Arthritis Res Ther       Date:  2017-11-02       Impact factor: 5.156

9.  Metabolites as drivers and targets in rheumatoid arthritis.

Authors:  Megan M Hanlon; Mary Canavan; Brianne E Barker; Ursula Fearon
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.